Japanese biotech raises $5.3M (Japan, May 2026)
Find the investors funding Health rounds
326,000+ verified VCs, angels and family offices — direct emails, check sizes and stage filters.
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trials - The Economic Times
A Japanese biotech company is developing a drug aimed at regrowing teeth. This innovative approach targets dental health and aims to provide a solution for tooth loss.
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trials The Economic Times
| Aug 31, 2026 | Atierra | $400K | Pre-seed | Japan |
| Aug 24, 2026 | Letara | $17.4M | — | Japan |
| Aug 24, 2026 | Genba Hub | $470K | Seed | Japan |
| Aug 18, 2026 | Gravis Robotics | $200.0M | — | Japan |
7,179 investors back startups in Japan
You just read who funded Japanese biotech. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.